Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor
Zhong Zheng, Xi‐Ping Huang, Thomas J. Mangano, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 7, pp. 3070-3081
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Tao Che, Susruta Majumdar, Saheem A. Zaidi, et al.
Cell (2018) Vol. 172, Iss. 1-2, pp. 55-67.e15
Open Access | Times Cited: 338
Synthon-based ligand discovery in virtual libraries of over 11 billion compounds
Arman Sadybekov, Anastasiia Sadybekov, Yongfeng Liu, et al.
Nature (2021) Vol. 601, Iss. 7893, pp. 452-459
Open Access | Times Cited: 308
Impact of GPCR Structures on Drug Discovery
Miles Congreve, Chris de Graaf, Nigel A. Swain, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 81-91
Open Access | Times Cited: 297
Untangling the complexity of opioid receptor function
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2514-2520
Open Access | Times Cited: 248
Biased Receptor Signaling in Drug Discovery
Terry Kenakin
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 267-315
Open Access | Times Cited: 246
GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures
Ichio Shimada, Takumi Ueda, Yutaka Kofuku, et al.
Nature Reviews Drug Discovery (2018) Vol. 18, Iss. 1, pp. 59-82
Open Access | Times Cited: 217
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Computational drug development for membrane protein targets
Haijian Li, Xiaolin Sun, Wenqiang Cui, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 229-242
Closed Access | Times Cited: 16
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kendall L. Mores, Benjamin Cummins, Robert J. Cassell, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 100
Biased ligands at opioid receptors: Current status and future directions
Tao Che, Hemlata Dwivedi‐Agnihotri, Arun K. Shukla, et al.
Science Signaling (2021) Vol. 14, Iss. 677
Open Access | Times Cited: 86
Molecular Basis of Opioid Action: From Structures to New Leads
Aashish Manglik
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 6-14
Open Access | Times Cited: 54
The Effects of Opioids on HIV Neuropathogenesis
Aniella Murphy, John M. Barbaro, Pablo Martínez-Aguado, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54
Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Federica Santino, Luca Gentilucci
Molecules (2023) Vol. 28, Iss. 1, pp. 346-346
Open Access | Times Cited: 21
Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors
Jolien De Neve, Thomas Barlow, Dirk Tourwé, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 6, pp. 828-870
Open Access | Times Cited: 34
Molecular glues as potential GPCR therapeutics
Bryan L. Roth, B. Krumm
Biochemical Pharmacology (2024) Vol. 228, pp. 116402-116402
Closed Access | Times Cited: 4
Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects
Seth F. Vigneron, Shohei Ohno, João Braz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Structure-Based Virtual Screening of Ultra-Large Library Yields Potent Antagonists for a Lipid GPCR
Arman Sadybekov, Rebecca L. Brouillette, Egor Marin, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1634-1634
Open Access | Times Cited: 36
Structure-based discovery of potent and selective melatonin receptor agonists
Nilkanth Patel, Xi‐Ping Huang, Jessica M. Grandner, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 35
Seeking (and Finding) Biased Ligands of the Kappa Opioid Receptor
Laura Bohn, Jeffrey Aubé
ACS Medicinal Chemistry Letters (2017) Vol. 8, Iss. 7, pp. 694-700
Open Access | Times Cited: 39
Selective kappa opioid antagonists for treatment of addiction, are we there yet?
Mohamed A. Helal, Eman S. Habib, Amar G. Chittiboyina
European Journal of Medicinal Chemistry (2017) Vol. 141, pp. 632-647
Closed Access | Times Cited: 34
Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
Zoe Li, Jie Liu, Fan Dong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7042-7042
Open Access | Times Cited: 8
Where Might Artificial Intelligence Be Going in Pharmaceutical Development?
Tibo Duran, Bodhisattwa Chaudhuri
Molecular Pharmaceutics (2024) Vol. 21, Iss. 3, pp. 993-995
Open Access | Times Cited: 2
Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging
Michael S. Placzek, Frederick A. Schroeder, Tao Che, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 1, pp. 384-395
Open Access | Times Cited: 22
Structure and dynamics of dynorphin peptide and its receptor
Guillaume Ferré, Georges Czaplicki, D. Pascal, et al.
Vitamins and hormones (2019), pp. 17-47
Open Access | Times Cited: 21
Comparative Docking to Distinct G Protein–Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy
Magdalena M. Scharf, Moritz Bünemann, Jillian G. Baker, et al.
Molecular Pharmacology (2019) Vol. 96, Iss. 6, pp. 851-861
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top